Abstract
Hypericin is a photosensitizer expressing high affinity for cancerous cells in vivo. Diagnosis of cancer based on hypericin fluorescence imaging has been successfully assessed in several clinical trials. Our final objective will be to evaluate the potential of hypericin fluorescence imaging to improve the efficacy of cervical cancer diagnosis performed on fixed cell smears obtained from liquid-based cytology. For this purpose, the mechanism of hypericin incorporation and localization in fixed HeLa cells using different incubation media and fixation conditions was investigated. Since the duration of fixation may play an important role, the influence of fixation time on hypericin incorporation in fixed HeLa cells was studied. The uptake and distribution of hypericin in fixed HeLa cells were found to be strongly dependent on the hypericin incubation medium: for a polar organic solvent such as the alcohol-based fixative, the localization was essentially perinuclear and nuclear; for cell culture medium supplemented with serum, the localization was cytoplasmic and non-specific; the highest incorporation was observed for the serum-free culture medium but mainly as non-fluorescent aggregates. The hypericin aggregation in the incubation medium, the passive diffusion and the partitioning between the cells and hypericin carriers seemed to be the major factors accounting for these results. The localization was found to be weakly dependent on fixation time, whereas fluctuations of hypericin fluorescence at short fixation time and stabilization after two days of fixation were observed. These results suggest that the fixed cells reached a steady state after two days of fixation.
Similar content being viewed by others
References
C. R. Parish, Fluorescent dyes for lymphocyte migration and proliferation studies, Immunol. Cell Biol., 1999, 77, 499–508.
R. M. Martin, H. Leonhardt and M. C. Cardoso, DNA labeling in living cells, Cytometry A, 2005, 67, 45–52.
D. Jocham, H. Stepp and R. Waidelich, Photodynamic diagnosis in urology: State-of-the-art, Eur. Urol., 2008, 53, 1138–1150.
N. Fotinos, M. A. Campo, F. Popowycz, R. Gurny and N. Lange, 5 aminolevulinic acid derivatives in photomedicine: Characteristics, application and perspectives, Photochem. Photobiol., 2006, 82, 994–1015.
W. W. L. Chin, P. S. P. Thong, R. Bhuvaneswari, K. C. Soo, P. W. S. Heng and M. Olivo, In vivo optical detection of cancer using chlorin e6 - polyvinylpyrrolidone induced fluorescence imaging and spectroscopy, BMC Med. Imaging, 2009, 9, 1–13.
G. A. Wagnières, W. M. Star and B. C. Wilson, In vivo fluorescence spectroscopy and imaging for oncological applications, Photochem. Photobiol., 1998, 68, 603–632.
A. Uzdensky, V. Iani, L.W. Ma and J. Moan, On hypericin application diagnosis and cancer treatment: Pharmacokinetics and photosensitizing efficiency in nude mice bearingWiDr carcinoma, Med. Laser Appl., 2006, 21, 271–276.
M. Olivo, W. Lau, V. Manivasager, R. Bhuvaneswari, Z. Wei, K. C. Soo, C. Cheng and P. H. Tan, Novel photodynamic diagnosis of bladder cancer: Ex vivo fluorescence cytology using hypericin, Int. J. Oncol., 2003, 23, 1501–1504.
L. O. Hamad, A. Vervoorts, T. Hennig and R. Bayer, Ex vivo photodynamic diagnosis to detect malignant cells in oral brush biopsies, Lasers Med. Sci., 2009, 25, 293–301.
A. Huygens, A. R. Kamuhabwa, T. Roskams, B. Van Cleynenbreugel, H. Van, Poppel and P. A. M. De Witte, Permeation of hypericin in spheroids composed of different grade transitional cell carcinoma cell lines and normal human urothelial cells, J. Urol., 2005, 174, 69–72.
A. Huygens, I. Crnolatac, J. Develter, B. Van Cleynenbreugel, T. Van, der Kwast and P. A. M. De Witte, Differential accumulation of hypericin in spheroids composed of T-24 transitional cell carcinoma cells expressing different levels of E-cadherin, J. Urol., 2008, 179, 2014–2019.
G. H. Williams, P. Romanowski, L. Morris, M. Madine, A.D. Mills, K. Stoeber, J. Marr, R. A. Laskey and N. Coleman, Improved cervical smears assessment using antibodies against proteins that regulate DNA replication, Proc. Natl. Acad. Sci. U. S. A., 1998, 95, 14932–14937.
S. R. Chen, Y. P. Luo, J. K. Zhang, W. Yang, Z. C. Zhen, L. X. Chen and W. Zhang, Study on immune function of dendritic cells in patients with esophageal carcinoma, World J. Gastroenterol., 2004, 10, 934–939.
International Agency for Research on Cancer, IARC handbooks of cancer prevention, IARC Press, Lyon, 2005, 10, 1–302.
N. Pace and G. Mackinney, Hypericin, the photodynamic pigment from St. John’swort, J. Am. Chem. Soc., 1941, 63, 2570–2574.
H. Brockmann, Centenary lecture - photodynamically active plant pigments, Proc. Chem. Soc. London, 1957, 11, 304–312.
A. Kamuhabwa, P. Agostinis, B. Ahmed, W. Landuyt, B. Van Cleynenbreugel, H. Van, Poppel and P. A. M. deWitte, Hypericin as a potential phototherapeutic agent in superficial transitional cell carcinoma of the bladder, Photochem. Photobiol. Sci., 2004, 3, 772–780.
C. L. L. Saw, M. Olivo, K. C. Soo and P. W. S. Heng, Delivery of hypericin for photodynamic applications, Cancer Lett., 2006, 241, 23–30.
M. A. D’Hallewin, P. A. De Witte, E. Waelkens, W. Merlevede and L. Baert, Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin, J. Urol., 2000, 164, 349–351.
M. A. D’Hallewin, A. R. Kamuhabwa, T. Roskams, P. A. M. De, Witte and L. Baert, Hypericin-based fluorescence diagnosis of bladder carcinoma, BJU Int., 2002, 89, 760–763.
H. G. Sim, W. K. O. Lau, M. Olivo, P. H. Tan and C. W. S. Cheng, Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma?, BJU Int., 2005, 95, 1215–1218.
P. S. P. Thong, M. Olivo, W. W. L. Chin, R. Bhuvaneswari, K. Mancer and K. C. Soo, Clinical application of fluorescence endoscopic imaging using hypericin for the diagnosis of human oral cavity lesions, Br. J. Cancer, 2009, 101, 1580–1584.
H. Lavu, K. Geary, H. R. Fetterman and R. E. Saxton, Pancreatic tumor detection using hypericin based fluorescence spectroscopy and cytology, in Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XIV, ed. D. Kessel, Spie-Int Soc Optical Engineering, Bellingham, 2005, pp. 282–290.
C. Y. Fu, B. Koon N.G. S. G. Razul, W. W. L. Chin, P. H. Tan, W. K. Lau and M. Olivo, Fluorescence detection of bladder cancer using urine cytology, Int. J. Oncol., 2007, 31, 525–530.
E. Peltier, Combination of a histological or cytological fixing agent and one or more photoactivable compounds of the quinone family, in particular hypericin, hypocrellin A and hypocrellin B, 2006, FR0503487 and US Patent Application 20090047704.
D. Dehn, K. C. Torkko and K. R. Shroyer, Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma, Cancer (Cancer Cytopathol.), 2007, 111, 1–14.
O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, protein measurement with the Folin phenol reagent, J. Biol. Chem., 1951, 193, 265–275.
O. H. Lowry, N. J. Rosebrough, A. L. Farr and R. J. Randall, protein measurement with the Folin phenol reagent, J. Biol. Chem., 1951, 193, 265–275.
G. Siboni, H. Weitman, D. Freeman, Y. Mazur, Z. Malik and B. Ehrenberg, The correlation between hydrophilicity of hypericins and helianthrone: internalization mechanisms, subcellular distribution and photodynamic action in colon carcinoma cells, Photochem. Photobiol. Sci., 2002, 1, 483–491.
I. Crnolatac, A. Huygens, P. Agostinis, A. R. Kamuhabwa, J. Maes, A. Van, Aerschot and P. A. M. De Witte, In vitro accumulation and permeation of hypericin and lipophilic analogues in 2-D and 3-D cellular systems, Int. J. Oncol., 2007, 30, 319–324.
S. Kascakova, Z. Nadova, A. Mateasik, J. Mikes, V. Huntosova, M. Refregiers, F. Sureau, J. C. Maurizot, P. Miskovsky and D. Jancura, High level of low-density lipoprotein receptors enhance hypericin uptake by U-87 MG cells in the presence of LDL, Photochem. Photobiol., 2008, 84, 120–127.
H. Fraenkelconrat and H. S. Olcott, The reaction of formaldehyde with proteins.5. Cross-linking between amino and primary amide or guanidyl groups, J. Am. Chem. Soc., 1948, 70, 2673–2684.
M. Y. Feldman, Reactions of nucleic acids and nucleoproteins with formaldehyde, Prog. Nucleic Acid Res. Mol. Biol., 1973, 13, 1–49.
H. Falk and J. Meyer, On the homo-association and heteroassociation of hypericin, Monatsh. Chem., 1994, 125, 753–762.
L. Burel and P. Jardon, Homo-association of hypericin in water and consequences on its photodynamic properties, J. Chim. Phys. Phys.- Chim. Biol., 1996, 93, 300–316.
T. Yamazaki, N. Ohta, I. Yamazaki and P. S. Song, Excited-state properties of hypericin - electronic-spectra and fluorescence decay kinetics, J. Phys. Chem., 1993, 97, 7870–7875.
E. M. Delaey, R. Obermueller, I. Zupko, D. De Vos, H. Falk and P. A. M. de Witte, In vitro study of the photocytotoxicity of some hypericin analogs on different cell lines, Photochem. Photobiol., 2001, 74, 164–171.
V. Senthil, J. W. Longworth, C. A. Ghiron and L. I. Grossweiner, Photosensitization of aqueous model systems by hypericin, Biochim. Biophys. Acta, Gen. Subj., 1992, 1115, 192–200.
S. Kascakova, M. Refregiers, D. Jancura, F. Sureau, J. C. Maurizot and P. Miskovsky, Fluorescence spectroscopic study of hypericinphotosensitized oxidation of low-density lipoproteins, Photochem. Photobiol., 2005, 81, 1395–1403.
V. Huntosova, L. Alvarez, L. Bryndzova, Z. Nadova, D. Jancura, L. Buriankova, S. Bonneau, D. Brault, P. Miskovsky and F. Sureau, Interaction dynamics of hypericin with low-density lipoproteins and U87-MG cells, Int. J. Pharm., 2010, 389, 32–40.
T. A. Theodossiou, J. S. Hothersall, P. A. De Witte, A. Pantos and P. Agostinis, The Multifaceted Photocytotoxic Profile of Hypericin, Mol. Pharmaceutics, 2009, 6, 1775–1789.
E. Buytaert, G. Callewaert, N. Hendrickx, L. Scorrano, D. Hartmann, L. Missiaen, J. R. Vandenheede, I. Heirman, J. Grooten and P. Agostinis, Role of endoplasmic reticulum depletion and multidomain proapoptotic BAX and BAK proteins in shaping cell death after hypericin-mediated photodynamic therapy, FASEB J., 2006, 20, 756–758.
N. D. Weber, B. K. Murray, J. A. North and S. G. Wood, The antiviral agent hypericin has in vitro activity against HSV-1 through nonspecific association with viral and cellular membranes, Antiviral Chem. Chemother., 1994, 5, 83–90.
H. Esterbauer, J. Gebicki, H. Puhl and G. Jurgens, The role of lipidperoxidation and antioxidants in oxidative modification of LDL, Free Radical Biol. Med., 1992, 13, 341–390.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vuong, T.T.K., Vever-Bizet, C., Bonneau, S. et al. Hypericin incorporation and localization in fixed HeLa cells for various conditions of fixation and incubation. Photochem Photobiol Sci 10, 561–568 (2011). https://doi.org/10.1039/c0pp00324g
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1039/c0pp00324g